MALDI Mass Spectrometry Imaging—Prognostic Pathways and Metabolites for Renal Cell Carcinomas

SIMPLE SUMMARY: Renal cell carcinoma (RCC) is the seventh most common cancer type and accounts for more than 80% of all renal tumors. Nevertheless, prognostic biomarkers for RCC are still missing. Therefore, we analyzed a large, multicenter cohort including the three most common RCC subtypes (clear...

Descripción completa

Detalles Bibliográficos
Autores principales: Erlmeier, Franziska, Sun, Na, Shen, Jian, Feuchtinger, Annette, Buck, Achim, Prade, Verena M., Kunzke, Thomas, Schraml, Peter, Moch, Holger, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Walch, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996951/
https://www.ncbi.nlm.nih.gov/pubmed/35406537
http://dx.doi.org/10.3390/cancers14071763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996951/
https://www.ncbi.nlm.nih.gov/pubmed/35406537
http://dx.doi.org/10.3390/cancers14071763

Ejemplares similares